It is crucial to define the epidemiology of both common and unusual endocrine and metabolic diseases for several reasons. Documenting the overall disease burden (prevalence) and risk of disease development (incidence) and the distribution of endocrine and metabolic disorders in population subgroups should 1) provide critical information for the appreciation of the societal burden of these conditions; 2) guide public health interventions; 3) establish research priorities; and 4) aid in the appropriate allocation of health care dollars. Furthermore, detailed information regarding the burden and distribution of endocrine disorders should help define current and future endocrine workforce requirements and shape strategies for their effective use[6>.

基于1个网页-相关网页